Sandy Spring Bank Evelo Biosciences, Inc. Transaction History

Sandy Spring Bank

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$6.07 - $12.0 $3,429 - $6,780	-565 Closed	0 $0
Q2 2021 Aug 09, 2021	BUY	$9.43 - $16.6 $943 - $1,660	100 Added 21.51%	565 $8,000
Q1 2021 May 03, 2021	SELL	$9.71 - $18.6 $10,535 - $20,181	-1,085 Reduced 70.0%	465 $5,000
Q4 2020 Feb 03, 2021	BUY	$3.91 - $12.28 $4,496 - $14,122	1,150 Added 287.5%	1,550 $19,000
Q3 2020 Nov 09, 2020	BUY	$3.81 - $5.73 $1,524 - $2,292	400 New	400 $2,000

Ticker EVLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,994,000
Description
Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. It is developing EDP1815, a whole-microbe candidate for the treatment of inflammatory diseases; and is in Phase 2 clinical trial for the treatment of psoriasis and atopic dermatitis, as well as for the hy...

Get notified when there are updates to the investment portfolio of Sandy Spring Bank, based on Form 13F filings with the SEC.

Stay updated on Sandy Spring Bank with notifications on news.